slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 35,971-36,000
Pages 2,019
Rows per page 30
Component
35,971-36,000 of 60,568
41
The slide illustrates the methodology for ranking neoantigens, likely for personalized cancer vaccine development.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
67
The table highlights that all tested Omicron-modified vaccines met the superiority criterion (lower bound of 95% CI for GMR > 1.0).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
69
The table highlights the seroresponse difference and non-inferiority status for participants without prior infection.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
74
The slide uses a circular phylogenetic tree to illustrate the dominance of the Omicron clade (GRA) in recent outbreak sequences.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
76
Includes a 3D structural model of the RBD with color-coded mutation sites and a corresponding table of amino acid changes.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
79
The chart shows that the Omi BA.4/5 and b2 + Omi BA.4/5 vaccines maintain higher neutralization ratios against Omicron sub-lineages compared to the original BNT162b2 vaccine.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
83
The slide uses a map-based visual to illustrate a hub-and-spoke network model for vaccine manufacturing.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
87
Shows log-scale reduction in CFU/ml for pathogens vs no significant impact on beneficial bacteria.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
88
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
93
The slide uses a Gantt-style visualization for clinical trial phases.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
99
The slide uses a comparison table to contrast early-line vs late-line settings across three key biological dimensions.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
104
Includes a pie chart of responder status and a line chart showing T-cell expansion over time, plus a summary table of median T-cell percentages.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
106
Kaplan-Meier plot showing significant difference in RFS between responders and non-responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
114
The table categorizes candidates by platform, indication, and current clinical milestone status.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
118
Data cut-off: August 31, 2020. MTD not reached.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
14
The table uses a hierarchical header structure to group APAC sub-regions.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · SolutionLoop · Logic Chain1 hit
20
Includes a footnote explaining the 'Other' revenue category.Canada Goose | Investor Presentation Deck | 24 slides · Canada Goose
Pitch deck Investor relations Beat · Business ModelLoop · Cost Of Inaction1 hit
04
Cano Health | Investor Day Presentation Deck | 105 slidesCano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
53
The slide emphasizes a lower patient-to-physician ratio and higher engagement frequency at Cano Health.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
76
The chart tracks membership count (bars) and MCR percentage (line) across six quarters, with a secondary table showing the number of centers.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
86
The slide highlights the significant increase in affiliate-based members, which is the primary driver of total membership growth.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
87
The slide highlights geographic expansion, specifically mentioning New York, New Jersey, and Arizona as new markets.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
91
Cano Health | Investor Day Presentation Deck | 105 slidesCano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
92
Cano Health | Investor Day Presentation Deck | 105 slidesCano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
94
The chart uses a waterfall structure to bridge individual revenue streams to a total revenue figure.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
96
The slide highlights the profitability difference between two business models.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
100
The slide uses a waterfall-style logic to build up to a $500M opportunity figure.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
103
Includes detailed footnotes explaining non-GAAP adjustments and LTM calculation methodology.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
10
The chart highlights a recovery and growth trend in revenue and EPS following a dip in FY2021.Capri Holdings | Results Presentation Deck | 17 slides · Capri Holdings
Conference presentation Investor relations Beat · EvidenceLoop · Logic Chain1 hit